Novel compounds

Details for Australian Patent Application No. 2007242851 (hide)

Owner Glaxo Group Limited

Inventors McLay, Iain McFarlane; Cooper, Anthony William James; Biggadike, Keith; Woollam, Grahame Robert; House, David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007242851

PCT Pub. Number WO2007/122165

Priority 0607840.6 20.04.06 GB; 0620382.2 13.10.06 GB; 0706516.2 03.04.07 GB; 0706515.4 03.04.07 GB

Filing date 18 April 2007

Wipo publication date 1 November 2007

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61P 5/44 (2006.01) Drugs for disorders of the endocrine system

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/122165 Priority application(s): WO2007/122165

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007242859-Substituted pyrazinone derivatives for use as a medicine

2007242842-2-substituted 4-benzylphthalazinone derivatives as histamine H1 and H3 antagonists